Tuesday, January 24, 2023

< + > The End Of Obesity

Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.

No comments:

Post a Comment

< + > Bonus Features – March 29, 2026 – 57% of execs say AI-based clinical tools are their top tech initiative, 57% of patients say AI isn’t mature enough for docs to trust it, plus 32 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...